Idera Pharmaceuticals, Inc.
IDRA
Get informed when a big investor buys or sells
+ FollowMarket Cap$0
Close$
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $-1,624,000.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-7.18 |
| Beta | 0 |
| Outstanding Shares | 7,448 |
Return
| Return on Equity | -182.04% |
|---|---|
| Return on Assets | -52.29% |
| Return on Invested Capital | -78.55% |
Valuation & Multiples
| P/E Ratio | -0.06 |
|---|---|
| PEG | -0.01 |
| Price to Sales | - |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.03 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.3 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Idera Pharmaceuticals, Inc.
CEO: Vincent Milano